Skip to main content
Back
Watch Compare

Atea Pharmaceuticals, Inc.

Data quality: 83%
AVIR
Nasdaq Manufacturing Chemicals
$5.79
▼ $0.14 (-2.36%)
Mkt Cap: 461.30 M
Price
$5.79
Mkt Cap
461.30 M
Day Range
$5.77 — $5.96
52-Week Range
$2.46 — $6.45
Volume
116,257
Open $5.86
50D / 200D Avg
$4.97
16.51% above
50D / 200D Avg
$3.73
55.12% above

Quick Summary

Key Takeaways

Negative free cash flow of -132.03 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-46.56%
Above sector avg (-51.02%)
ROIC-41.17%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio16.66
Interest CoverageN/A

Valuation

PE (TTM)
-2.91
Below sector avg (-1.98)
P/B Ratio1.46
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E -2.9 -2.0
P/B 1.5 5.1
ROE % -46.6 -51.0
Net Margin % — -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

ETFs Holding This Stock

AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.03% weight
AVUS logo AVUS Avantis U.S. Equity ETF
0.00% weight
EBI logo EBI Longview Advantage ETF
0.00% weight
IWV logo IWV iShares Russell 3000 ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -158.35 M
ROE -46.56% ROA -43.11%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -132.03 M
ROIC -41.17% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 16.66
Interest Coverage N/A Asset Turnover N/A
Working Capital 315.96 M Tangible Book Value 315.78 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.91 Forward P/E N/A
P/B Ratio 1.46 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -28.62%
Market Cap 461.30 M Enterprise Value 383.96 M
Per Share
EPS (Diluted TTM) -1.94 Revenue / Share N/A
FCF / Share -1.66 OCF / Share -1.66
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 83.38%
SBC-Adj. FCF -160.89 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — 351.37 M 351.37 M
Net Income -158.35 M -168.39 M -135.96 M -115.91 M 121.19 M
EPS (Diluted) -1.94 -2.00 -1.63 -1.39 1.37
Gross Profit — — — — —
Operating Income -180.89 M -192.95 M -164.16 M -130.65 M 138.38 M
EBITDA — — — — —
R&D Expenses 148.02 M 144.10 M 114.24 M 81.94 M 167.21 M
SG&A Expenses — — — — —
D&A 416,000.0 416,000.0 416,000.0 260,000.0 29,000.0
Interest Expense — — — — —
Income Tax -6.16 M 925,000.0 1.02 M -3.59 M 17.40 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 315.22 M 464.67 M 594.97 M 666.71 M 772.89 M
Total Liabilities 39.78 M 25.80 M 39.78 M 26.14 M 62.82 M
Shareholders' Equity 275.43 M 438.87 M 555.19 M 640.57 M 710.08 M
Total Debt — — — — —
Cash & Equivalents 95.71 M 64.70 M 143.82 M 188.46 M 764.38 M
Current Assets 310.99 M 462.36 M 590.46 M 660.92 M 772.40 M
Current Liabilities 39.78 M 18.60 M 32.38 M 18.48 M 56.88 M